Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) to present at 42nd Annual J.P. Morgan Healthcare Conference

SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 42^nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Adaptive Biotechnologies’ management is scheduled to present on Tuesday, January 9th at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations
201-396-1687
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Erica Jones, Associate Director, Corporate Communications
206-279-2423
media@adaptivebiotech.com

FAQ

What is the latest announcement from Adaptive Biotechnologies Corporation (Nasdaq: ADPT)?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) has announced its participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

When is Adaptive Biotechnologies Corporation (Nasdaq: ADPT) scheduled to present at the conference?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) is scheduled to present on Tuesday, January 9th at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Where can interested parties access the live webcast of the presentation?

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.